CUAMC
PACB icon

China Universal Asset Management Company’s Pacific Biosciences PACB Stock Holding History

China Universal Asset Management Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83K Sell
49,432
-4,160
-8% -$6.05K 0.01% 428
2026
Q1 		$70.7K Buy
53,592
+4,396
+9% +$7.86K 0.01% 438
2025
Q4 		$92K Sell
49,196
-3,454
-7% -$6.64K 0.01% 414
2025
Q3 		$67.4K Sell
52,650
-9,540
-15% -$12.9K 0.01% 413
2025
Q2 		$77.1K Buy
62,190
+5,339
+9% +$6.17K 0.01% 385
2025
Q1 		$67.1K Sell
56,851
-3,137
-5% -$4.81K 0.01% 392
2024
Q4 		$110K Buy
59,988
+5,653
+10% +$11K 0.01% 380
2024
Q3 		$92.4K Buy
54,335
+20,417
+60% +$33.5K 0.01% 362
2024
Q2 		$46.5K Sell
33,918
-19,530
-37% -$39.4K 0.01% 362
2024
Q1 		$200K Buy
53,448
+20,593
+63% +$121K 0.03% 288
2023
Q4 		$322K Buy
32,855
+12,628
+62% +$103K 0.06% 169
2023
Q3 		$169K Buy
20,227
+3,149
+18% +$36K 0.05% 156
2023
Q2 		$227K Sell
17,078
-73
-0.4% -$887 0.07% 126
2023
Q1 		$199K Buy
17,151
+1,051
+7% +$10.4K 0.07% 117
2022
Q4 		$132K Buy
16,100
+13,995
+665% +$121K 0.05% 114
2022
Q3 		$12K Buy
+2,105
New +$12.1K 0.01% 187

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

China Universal Asset Management Company's PACB Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Pacific Biosciences (PACB) stake by 7.8% in Q2 2026, selling an estimated $6.05K and leaving 49,432 shares worth $83K. The position accounts for 0.01% of the portfolio, ranked #428.

China Universal Asset Management Company first reported a position in PACB in Q3 2022 and has held it in 16 quarters since. The position peaked at $322K in Q4 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • China Universal Asset Management Company held 49,432 shares of Pacific Biosciences worth $83K as of Q2 2026.
  • China Universal Asset Management Company sold 4,160 Pacific Biosciences shares in Q2 2026, an estimated $6.05K.
  • Pacific Biosciences made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #428 holding.
  • China Universal Asset Management Company first reported a position in Pacific Biosciences in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Pacific Biosciences position peaked at $322K in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.